glp-1 pill news today World Health Leaders | FDA Approves First Oral Obesity Pill, Novo Nordisk to Launch in 2026 The FDA's approval of Novo Nordisk's first oral GLP-1 Orforglipron (Foundayo): Benefits, Uses &
Pay in 4 interest-free payments of $6.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6






























